Alex Zhavoronkov

Alex Zhavoronkov is a pioneer in applying AI to drug discovery and aging research. His company Insilico Medicine uses generative AI and deep learning to design novel drug candidates, achieving unprecedented speed from target discovery to clinical trials. Zhavoronkov's work on aging biomarkers and AI-designed molecules has advanced the field of longevity research alongside oncology applications.

Alex Zhavoronkov是将AI应用于药物发现和衰老研究的先驱。他的公司Insilico Medicine使用生成AI和深度学习设计新型候选药物，从靶点发现到临床试验达到了前所未有的速度。Zhavoronkov在衰老生物标志物和AI设计分子方面的工作推进了长寿研究领域以及肿瘤学应用。